Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects-Reference-Cited by-同舟云学术

Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Published:2022-08-31 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Kerr Lucy,Baldi Fernando,Lobo Raysildo,Assagra Washington Luiz,Proença Fernando Carlos,Chamie Juan J,Hibberd Jennifer A,Kory Pierre,Cadegiani Flavio A

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference32 articles.

1. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug;Mastrangelo E;J Antimicrob Chemother,2012

2. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus;Wagstaff KM;Biochem J,2012

3. Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations;Crump A;J Antibiot (Tokyo),2017

4. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen;Heidary F;J Antibiot (Tokyo),2020

5. Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment;Li N;J Cell Physiol,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticipation under the human right to science (HRS): sketching the public institutional framework. The example of scientific responses to the appearance of SARS-CoV-2;The International Journal of Human Rights;2023-10-17

2. Published benefits of ivermectin use in Itajaí, Brazil for COVID-19 infection, hospitalisation, and mortality are entirely explained by statistical artefacts;2023-08-15

3. COVID-19 Excess Deaths in Peru’s 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State;Cureus;2023-08-08